Association of urinary 11-dehydro-thromboxane b2 levels in smoking, smoking cessation and tobacco heating system use


Abstract

Smoking has been associated with cardiovascular disease and there is evidence that this might be mediated by the increased production of thromboxane. Whether metabolites of thromboxane, such as 11-dehydro-thromboxane b2 (TXB2), could be used as a biomarker of risk in the assessment of candidate modified risk tobacco products (MRTPS) is not clear. The aim of this literature review and meta-analysis (MA) was to determine the association of smoking status and TXB2 levels. Additionally we evaluated the effect of smoking cessation and the use of a tobacco heated system (THS) currently in development, to urinary levels of 11-dehydro-thromboxane B2. 

association-of-urinary-11-dehydro-thromboxane-b2-levels-in-smoking-smoking-cessation-and-tobacco-hea